{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Baltimore",
      "address_1": "Harborplace Tower",
      "reason_for_recall": "Failed Impurities/Degradation Specification; high out of specification results observed",
      "address_2": "111 S Calvert St Fl 21st",
      "product_quantity": "876 bottles",
      "code_info": "K800475 exp. date May 2020  K800477 exp. date June 2020",
      "center_classification_date": "20200303",
      "distribution_pattern": "Product was distributed throughout the United States.",
      "state": "MD",
      "product_description": "Desoximetasone Topical Spray, 0.25%, 2.5 mg desoximetasone, 100 mL bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD",
      "report_date": "20200311",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Lupin Pharmaceuticals Inc.",
      "recall_number": "D-0866-2020",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "85015",
      "termination_date": "20210603",
      "recall_initiation_date": "20200219",
      "postal_code": "21202-6174",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}